Clinical Trial Update: Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD) [NA]

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating albuterol and oxandrolone in patients with facioscapulohumeral muscular dystrophy (FSHD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facioscapulohumeral Muscular Dystrophy

Drugs mentioned

• Albuterol (albuterol)
• Oxandrolone (Oxandrolone)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Muscular Dystrophies | NA | Status: COMPLETED